title: Pharmacotherapy of pediatric advanced life support and toxicological emergencies.
abstract: Guidelines for pediatric advanced life support have been available for nearly a quarter of a century. Recommendations for the pharmacological management of pediatric cardiac arrest have changed over these years. Several important differences have been observed between adult advanced cardiac life support and pediatric advanced life support that must be recognized when children require resuscitation, such as the cause of the arrest, age-specific monitoring parameters, weight-based medication dosing, and obstacles in obtaining venous access. To make matters more complicated, differences also exist across neonatal and pediatric age spectrums. In addition, some toxicological emergencies commonly occurring in children require pharmacological management with agents that have a unique mechanism of action for cardiac support.
authors.affiliation: Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
authors.forename: Lauren M
authors.initials: LM
authors.lastname: Dandeles
authors.forename: Kirsten H
authors.initials: KH
authors.lastname: Ohler
mesh_terms: D022561:Advanced Cardiac Life Support / Q000379:methods* / Q000451:nursing; D003422:Critical Care; D004358:Drug Therapy / Q000379:methods* / Q000451:nursing; D004630:Emergencies; D006323:Heart Arrest / Q000451:nursing / Q000628:therapy*; D006801:Humans; D010372:Pediatrics / Q000379:methods*